Safety and immunogenicity report from the Com-COV study – A single-blind randomised non-inferiority trial… disq.us/t/3ygu2g6

Just published The Lancet A randomized mix and match trial of AZ and Pfizer vaccination in >800 people shows that mixing is safe and can engender at least as good, if not better, immune response thelancet.com/action/showPdf… by Xinxue Liu and colleagues

This is a game changer. A single dose typhoid conjugate vaccine is highly efficacious in all ages including children younger than 2 years. ⁦UMSOM Center for Vaccine Dev. & Global Health⁩ ⁦University of Maryland School of Medicine⁩ ⁦Andrew Pollard⁩ icddr,b⁩ #takeontyphoid sciencedirect.com/science/articl…

What vaccination strategies lead to the highest level of neutralizing Ab, immune response, in rank order? 1. Prior covid + mRNA 1-dose 2. Adenoviral-vector vaccine 1st dose, mRNA 2nd dose 3. 2 doses mRNA 4. 2 doses adenoviral vector (AZ data)

Israel's 4th wave An outstanding Financial Times editorial that succinctly summarizes the data, knowns, unknowns, boosters, need for masks among vaccinated ft.com/content/572112…

Although the writer does not mention absolutely all the relevant evidence, this is a spectacularly clear explanation as to why this is not in any way a straightforward decision and why I’d advise you to treat anyone who tells you otherwise with suspicion. bbc.co.uk/news/health-58…

#BSI21 award for Global Impact & Innovation fir absolutely everyone who contributed to the development of the Oxford/AstraZeneca vaccine. Feel emotional! Well done all

Out today COV-BOOST trial results. Six highly effective vaccines for boosting. Promising news with omicron emerging. The most collaborative (& fastest!) trial I have worked on. Amazing stats team work with Xinxue Liu Leila bit.ly/3deXMJ0 bbc.co.uk/news/health-59…

The COV-BOOST trial suggests fractional vaccine doses may be important(effective but still highly reactive). Chuffed to be working on the Young Adults Fractional Dosing trial tinyurl.com/2p86ypvn with the fantastic Leila Saul Faust Xinxue Liu PHARMExcel Oxford Vaccine Group

New case study: Read how we overcame unprecedented challenges in the Phase II #COVBoost #clinical trial and delivered outcomes in record time. Full case study here: pharmexcel-cro.com/news/adopting-…

Get a second booster? I reviewed all 3 studies of a 4th shot vs 3-shots and other relevant data, among with recommendations erictopol.substack.com/publish/post/5…

The brilliant ⁦Merryn Voysey⁩, lead statistician on Oxford-AstraZeneca vaccine, wins Australian of the year (U.K.) award two years from the first trial dose ⁦Oxford Vaccine Group⁩

A super day at Windsor Castle with HRH Prince of Wales, who asked about the team Oxford Vaccine Group

We are looking for young people aged (12-15½ years) who have previously received two doses of Pfizer COVID-19 vaccine in the national vaccination programme to take part in a third dose COVID-19 vaccine study. For more information or to find your closest study site 🔻

Our researchers have reported new findings from a study exploring how certain genes can help generate a strong immune response following vaccination with two commonly used COVID-19 vaccines. Department of Paediatrics | University of Oxford Read more 🔻

🎉 Congratulations to our Xinxue Liu on becoming an Associate Professor in Medical Statistics and Epidemiology! 🌟 The entire Oxford Vaccine Group is bursting with pride! More on Xinxue's work: tinyurl.com/2p8hdrv4 Department of Paediatrics | University of Oxford

Excited to host a 2 day OPTIMMS Annual Principal Investigators’ Meeting in Uganda! OPTIMMS trial is a pivotal study aimed at identifying optimal immunisation schedules for infants. We are joined by dignitaries from the Ministry of Health- Uganda, UNEPI, World Health Organization (WHO) #ResearchCollaboration

Join us at the Oxford Vaccine Group for groundbreaking research studies! Don't miss out – enroll now as we're actively seeking participants for our latest studies. 🔍 Click the link below to discover how you can get involved: tinyurl.com/3pzmm8ke #GetInvolved 🧪🔬

Traing at Dhaka TyVAC. Yama F Mujadidi Merryn Voysey #ovg #Oxforduniversity

TyVac-Nepal team celebrate 20,000 children vaccinated in Patan, Nepal. #stoptyphoid Incredible achievement. Take on Typhoid Gates Foundation Gavi, the Vaccine Alliance World Health Organization (WHO) Seth Berkley Oxford Vaccine Group @OUCRU_Vietnam